Bulletin
Investor Alert

New York Markets Open in:

ResMed Inc.

NYS: RMD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 15, 2022, 6:35 p.m.

RMD
/zigman2/quotes/204675483/composite

$

236.60

Change

-0.51 -0.22%

Volume

Volume 9,520

Quotes are delayed by 20 min

/zigman2/quotes/204675483/composite

Previous close

$ 239.99

$ 237.11

Change

-2.88 -1.20%

Day low

Day high

$235.00

$241.19

Open

52 week low

52 week high

$189.40

$301.34

Open

Company Description

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the following segments: Sleep and Respiratory Care, and Software as a Service. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment engages in the supply of business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Valuation

P/E Current

45.27

P/E Ratio (with extraordinary items)

45.26

P/E Ratio (without extraordinary items)

39.55

Price to Sales Ratio

8.61

Price to Cash Flow Ratio

87.78

Enterprise Value to EBITDA

29.94

Enterprise Value to Sales

9.99

Efficiency

Total Asset Turnover

0.73

Liquidity

Current Ratio

2.80

Quick Ratio

1.72

Cash Ratio

0.40

Profitability

Gross Margin

55.71

Operating Margin

27.96

Pretax Margin

26.84

Net Margin

21.78

Return on Assets

15.87

Return on Equity

24.96

Return on Total Capital

25.14

Capital Structure

Total Debt to Total Assets

18.01

Officers and Executives

Name Age Officer Since Title
Dr. Peter C. Farrell 79 1989 Executive Chairman
Mr. Michael J. Farrell 49 2000 Chief Executive Officer & Director
Mr. Robert Andrew Douglas 59 2001 Chief Operating Officer
Mr. Brett A. Sandercock 53 1998 Vice President-Treasury & Finance
Ms. Urvashi Tyagi - 2022 Chief Technology Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/22/2022 Brett A. Sandercock
Chief Financial Officer
7,500   Disposition at $235 per share. 1,762,500
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $224.94 per share. 1,276,534
07/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
07/05/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $212.33 per share. 328,049
06/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $202.54 per share. 1,149,414
06/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
06/03/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $209.44 per share. 323,584
05/16/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $196.61 per share. 1,115,761
05/16/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
05/03/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $200 per share. 309,000
04/18/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $232.41 per share. 1,318,926
04/18/2022 Robert Andrew Douglas
President and COO
8,000   Disposition at $233.29 per share. 1,866,320
04/18/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
04/18/2022 Robert Andrew Douglas
President and COO
8,000   Derivative/Non-derivative trans. at $58.24 per share. 465,920
04/11/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Disposition at $247 per share. 617,500
04/11/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
04/04/2022 David Brian Pendarvis
Chief Administrative Officer
1,544   Disposition at $246.6 per share. 380,750
/news/latest/company/us/rmd

MarketWatch News on RMD

  1. ResMed Inc. stock falls Monday, underperforms market

    5:19 p.m. Aug. 15, 2022

    - MarketWatch Automation

  2. ResMed Inc. stock underperforms Friday when compared to competitors

    5:18 p.m. Aug. 12, 2022

    - MarketWatch Automation

  3. Illumina, Rivian, Toast, and More Stock Market Movers

    8:56 a.m. Aug. 12, 2022

    - Barron's Online

  4. ResMed Inc. stock underperforms Thursday when compared to competitors

    5:18 p.m. Aug. 11, 2022

    - MarketWatch Automation

  5. ResMed Inc. stock rises Wednesday, outperforms market

    5:19 p.m. Aug. 10, 2022

    - MarketWatch Automation

  6. ResMed Inc. stock outperforms market on strong trading day

    5:19 p.m. Aug. 9, 2022

    - MarketWatch Automation

  7. ResMed Inc. stock falls Monday, underperforms market

    5:19 p.m. Aug. 8, 2022

    - MarketWatch Automation

  8. ResMed Inc. stock outperforms competitors on strong trading day

    5:19 p.m. Aug. 5, 2022

    - MarketWatch Automation

  9. ResMed Inc. stock falls Thursday, underperforms market

    5:19 p.m. Aug. 4, 2022

    - MarketWatch Automation

  10. ResMed Inc. stock rises Wednesday, still underperforms market

    5:19 p.m. Aug. 3, 2022

    - MarketWatch Automation

  11. ResMed Inc. stock outperforms competitors on strong trading day

    5:19 p.m. Aug. 2, 2022

    - MarketWatch Automation

  12. ResMed Inc. stock falls Monday, underperforms market

    5:19 p.m. Aug. 1, 2022

    - MarketWatch Automation

  13. ResMed Inc. stock underperforms Friday when compared to competitors

    5:18 p.m. July 29, 2022

    - MarketWatch Automation

  14. ResMed Inc. stock rises Thursday, still underperforms market

    5:18 p.m. July 28, 2022

    - MarketWatch Automation

  15. ResMed Inc. stock rises Wednesday, still underperforms market

    5:19 p.m. July 27, 2022

    - MarketWatch Automation

  16. ResMed Inc. stock outperforms competitors on strong trading day

    5:18 p.m. July 25, 2022

    - MarketWatch Automation

  17. ResMed Inc. stock falls Friday, still outperforms market

    5:18 p.m. July 22, 2022

    - MarketWatch Automation

  18. Loading more headlines...
/news/nonmarketwatch/company/us/rmd

Other News on RMD

  1. ResMed downgraded at JPMorgan and RBC despite earnings beat

    12:27 p.m. Aug. 12, 2022

    - Seeking Alpha

  2. 10-K: RESMED INC

    6:11 a.m. Aug. 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. ResMed Inc. 2022 Q4 - Results - Earnings Call Presentation

    9:54 p.m. Aug. 11, 2022

    - Seeking Alpha

  4. ResMed (RMD) Q4 2022 Earnings Call Transcript

    8:31 p.m. Aug. 11, 2022

    - Motley Fool

  5. Notable earnings after Thursday's close

    5:35 p.m. Aug. 10, 2022

    - Seeking Alpha

  6. ResMed Q4 2022 Earnings Preview

    5:35 p.m. Aug. 10, 2022

    - Seeking Alpha

  7. Becton, Dickinson: Acquisitions Underwhelming

    6:49 p.m. July 27, 2022

    - Seeking Alpha

  8. XLV: Likely To Underperform Long-Term

    6:00 a.m. July 21, 2022

    - Seeking Alpha

  9. ResMed (RMD) Presents On Acquisition Of MedifoxDan - Slideshow

    3:01 p.m. June 17, 2022

    - Seeking Alpha

  10. 4 Big Upside Potential Picks From RBC Capital Markets

    10:32 a.m. June 8, 2022

    - 247WallSt.com

  11. Loading more headlines...

At a Glance

ResMed, Inc.

9001 Spectrum Center Boulevard

San Diego, California 92123

Phone

1 8588365000

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

06/2023

Revenue

$3.58B

Net Income

$779.44M

Employees

8,160

/news/pressrelease/company/us/rmd

Press Releases on RMD

  1. S&P 500 Movers: ILMN, BR

    3:18 p.m. Aug. 12, 2022

    - MarketNewsVideo.com

  2. How To Trade Resmed RMD

    3:02 a.m. Aug. 11, 2022

    - Stock Traders Daily

  3. Invalid Iqfeed Symbol (RMD) Trading Report

    11:26 a.m. Aug. 1, 2022

    - Stock Traders Daily

  4. Sleep Apnea Device Market Share to Witness Steady Rise by 2029

    7:48 a.m. July 29, 2022

    - AmericaNewsHour

  5. Trend Tracker for Resmed RMD

    4:59 p.m. July 22, 2022

    - Stock Traders Daily

  6. Resmed RMD Investment Report

    9:15 a.m. July 9, 2022

    - Stock Traders Daily

  7. How To Trade Resmed RMD

    3:38 p.m. June 29, 2022

    - Stock Traders Daily

  8. When Resmed (RMD) Moves Investors should Listen

    8:58 p.m. June 19, 2022

    - Stock Traders Daily

  9. Resmed RMD Trading Signals

    8:52 p.m. June 8, 2022

    - Stock Traders Daily

  10. Loading more headlines...
Link to MarketWatch's Slice.